Results 41 to 50 of about 1,512,475 (325)

Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape

Human Vaccines & Immunotherapeutics, 2023
Messenger RNA (mRNA)-based vaccine platforms used for the development of mRNA-1273 and BNT162b2 have provided a robust adaptable approach to offer protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Rituparna Das, Randall N. Hyer, Paul Burton, Jacqueline M. Miller, Barbara J. Kuter   +4 more
doaj   +1 more source

Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine

Cureus, 2021
The mRNA-1273 vaccine, popularly called the "Moderna vaccine" is being widely administered in the United States for the prevention of COVID-19 infection since December 2020.
S. Malayala, Gisha Mohan, D. Vasireddy, Paavani Atluri   +3 more
semanticscholar   +1 more source

Narratives of Modern Architecture: learning at the intersection of cross-historical constructions [PDF]

, 2016
This paper presents the results of experimental course work in 2015 with secondyear students at IE School of Architecture and Design under the auspices of Culture and Theory in Architecture I.
Vela Castillo, José
core   +2 more sources

Século XXI: educação moderna ou pós-moderna?

Revista Iberoamericana de Educación, 2013
La sociedad tiene pasado por conflictos en el plan axiológico, ético, de identidad, entre la verdad y el mito, confirmación y negación de la historia que repercute directamente en la producción académica y en los rumbos que las ciencias deben seguir.
Montysuma, Hilda, Bonito, Jorge
openaire   +5 more sources

Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis

Canadian Medical Association Journal, 2022
Background: Differences in immunogenicity between mRNA SARS-CoV-2 vaccines have not been well characterized in patients undergoing dialysis. We compared the serologic response in patients undergoing maintenance hemodialysis after vaccination against SARS-
K. Yau, Christopher T Chan, K. Abe, Yi-bin Jiang, M. Atiquzzaman, S. Mullin, Ellen Shadowitz, Lisa Liu, Ema Kostadinovic, Tatjana Šuković, Anny Gonzalez, M. McGrath-Chong, M. Oliver, J. Perl, J. Leis, S. Bolotin, V. Tran, A. Levin, P. Blake, K. Colwill, A. Gingras, M. Hladunewich   +21 more
semanticscholar   +1 more source

“God werkt geometrisch”–“los holandeses” lo hacen de otra forma: cosmológico-matemática, teosófica y arquitectónicamente [PDF]

, 2010
Las tesis de una edad moderna ex-nihilo, creada a sí misma, como prejuicio moderno viene ocultando, a pesar de los estudios minuciosos al respecto, las conexiones más complejas en la formación de la arquitectura moderna que terminan sepultadas bajo las
Oechslin, W. (Werner)
core   +2 more sources

Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine

Nature Communications, 2022
Real-world analysis of the incidence of SARS-CoV-2 infection post vaccination is important in determining the comparative effectiveness of the available vaccines.
Nazmul Islam, N. Sheils, M. Jarvis, K. Cohen   +3 more
semanticscholar   +1 more source

A Case Report: Long Post-COVID Vaccination Syndrome During the Eleven Months After the Third Moderna Dose

Cureus, 2022
It is undisputed that anti-SARS-CoV-2 vaccines can have side effects. Long post-COVID vaccination syndrome (LPCVS) is one of them and is often neglected. It persists 11 months after the third mRNA-1273 (Moderna) vaccine dose has not been reported.
J. Finsterer
semanticscholar   +1 more source

Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases

Vaccines, 2022
The purpose of this study was to evaluate the efficacy and safety of the Moderna-1273 mRNA vaccine for SARS-CoV-2 in patients with immune-mediated diseases under different treatments.
M. De Santis, F. Motta, N. Isailovic, Massimo Clementi, E. Criscuolo, Nicola Clementi, A. Tonutti, Stefano Rodolfi, E. Barone, F. Colapietro, A. Ceribelli, M. Vecellio, N. Luciano, G. Guidelli, M. Caprioli, Clara Rezk, L. Canziani, E. Azzolini, L. Germagnoli, N. Mancini, A. Lleo, C. Selmi   +21 more
semanticscholar   +1 more source

Subacute Thyroiditis After Receiving the mRNA COVID-19 Vaccine (Moderna): The First Case Report and Literature Review in Korea

Journal of Korean medical science, 2022
Subacute thyroiditis (SAT) is a painful thyroiditis that often requires steroid therapy. Here, we report the first case of severe SAT in a patient who received the first dose of mRNA coronavirus disease 2019 (COVID-19) vaccination.
M. Jhon, Sun-Ho Lee, T. Oh, Ho-Cheol Kang   +3 more
semanticscholar   +1 more source